LINX™ reflux management system: Magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease

Expert Review of Gastroenterology and Hepatology

Volumn 6, Issue 6, 2012, Pages 667-674

  Bonavina, Luigi ^a   Demeester, Tom R ^b   Ganz, Robert A ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

adenocarcinoma; Barrett's; esophagitis; fundoplication; gastroesophageal junction; gastroesophageal reflux disease; LINX Reflux Management System; lower esophageal sphincter; magnetic sphincter augmentation; Nissen; PPI; regurgitation

Indexed keywords

BARIUM MEAL; CLINICAL EFFECTIVENESS; DIGESTIVE SURGICAL DEVICE; DYSPHAGIA; EQUIPMENT DESIGN; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; ESOPHAGUS MANOMETRY; GAS BLOAT SYNDROME; GASTROESOPHAGEAL REFLUX; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROCESS DESIGN; PROCESS TECHNOLOGY; QUALITY OF LIFE; REPRODUCIBILITY; REVIEW; RISK BENEFIT ANALYSIS; STOMACH FUNDOPLICATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TREATMENT INDICATION;

ESOPHAGEAL SPHINCTER, LOWER; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; MAGNETS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION;

EID: 84871019730     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.12.47     Document Type: Review

References (26)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastrooesophageal reflux disease: a systematic review. Gut 54(5), 710-717 (2005). (Pubitemid 40559260)
2. Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology 122(5), 1500-1511 (2002). (Pubitemid 34465190)
3. Shaheen NJ, Hansen RA, Morgan DR et al. The burden of gastrointestinal and liver diseases, 2006. Am. J. Gastroenterol. 101(9), 2128-2138 (2006). (Pubitemid 44337640)
4. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin. Gastroenterol. Hepatol. 2(8), 656-664 (2004). (Pubitemid 39013424)
5. AGA Institute. GERD Patient Study -Patients and their Medications. Harris Interactive, NY, USA (2008).
6. Sharma N, Agrawal A, Freeman J, Vela MF, Castell D. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin. Gastroenterol. Hepatol. 6(5), 521-524 (2008).
7. Lord RV, DeMeester SR, Peters JH et al. Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J. Gastrointest. Surg. 13(4), 602-610 (2009).
8. Vela M, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz P, Castell D. Simultaneous intraesophageal impedance and pH measurement of acid and non-acid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120, 1599-1606 (2001). (Pubitemid 32523479)
9. Peters J, DeMeester T, Crookes P, Oberg S, deVos Shoop M, Hagen J, Bremner C. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: a prospective evaluation of 100 patients with 'typical' symptoms. Ann. Surg. 228, 40-50 (1998). (Pubitemid 30190314)
10. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann. Intern. Med. 120(3), 211-215 (1994).
11. O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am. J. Med. 118(7), 778-781 (2005). (Pubitemid 40897665)
12. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294(23), 2989-2995 (2005). (Pubitemid 41817660)
13. Poulsen AH, Christensen S, McLaughlin JK et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br. J. Cancer 100(9), 1503-1507 (2009).
14. Hunter JG, Smith CD, Branum GD et al. Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann. Surg. 230(4), 595-604; discussion 604 (1999).
15. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am. J. Med. 114(1), 1-5 (2003). (Pubitemid 36126507)
16. Richter JE, Dempsey DT. Laparoscopic antireflux surgery: key to success in the community setting. Am. J. Gastroenterol. 103(2), 289-291 (2008). (Pubitemid 351248717)
17. Thijssen AS, Broeders IA, de Wit GA, Draaisma WA. Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature. Surg. Endosc. 25(10), 3127-3134 (2011).
18. Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg. Endosc. 20(11), 1698-1701 (2006). (Pubitemid 44715532)
19. Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T, DeMeester TR. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest. Endosc. 67(2), 287-294 (2008). (Pubitemid 351146612)
20. Bonavina L, Saino GI, Bona D et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J. Gastrointest. Surg. 12(12), 2133-2140 (2008).
21. Bonavina L, DeMeester T, Fockens P et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann. Surg. 252(5), 857-862 (2010).
22. Lipham JC, DeMeester TR, Ganz RA et al. The LINX reflux management system: confirmed safety and efficacy now at 4 years. Surg. Endosc. 26, 2944-2949 (2012).
23. Migliore A, Corio M, Paone S, Jefferson T, Cerbo M. Horizon Scanning Report No. 9. Implantable Device for Patients with Gastro-Oesophageal Reflux Disease. Agenas, Agenzia nazionale per i servizi sanitari regionali, Rome, Italy (2012).
24. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis. Esophagus 20(2), 130-134 (2007). (Pubitemid 46562851)
25. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD; SAGES Guidelines Committee. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg. Endosc. 24(11), 2647-2669 (2010).
26. Broeders JA, Roks DJ, Jamieson GG, Devitt PG, Baigrie RJ, Watson DI. Five-year outcome after laparoscopic anterior partial versus Nissen fundoplication: four randomized trials. Ann. Surg. 255(4), 637-642 (2012).